NCT04642742 is a clinical trial of Chewable plant sterol in Hyperlipidemia, sponsored by Piper Biosciences, Inc..

Who is sponsoring NCT04642742?

NCT04642742 is sponsored by Piper Biosciences, Inc..

What drugs are being tested in NCT04642742?

Interventions in NCT04642742: Chewable plant sterol.

What condition does NCT04642742 study?

NCT04642742 studies Hyperlipidemia.

Is NCT04642742 still recruiting?

NCT04642742 is currently status unknown. Last updated 24 November 2020.

Last reviewed 2020-11-24 · How we verify

NCT04642742

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of a Chewable Plant Sterol Supplement on LDL-C in A Real-World Setting

Status unknown Last updated 24 November 2020

What this trial tests

trial testing Chewable plant sterol in Hyperlipidemia in 150 participants. Status unknown.

Timeline

25 November 2020

Primary endpoint
11 November 2021

11 November 2021

Quick facts

Lead sponsor	Piper Biosciences, Inc.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	25 November 2020
Primary completion	11 November 2021
Estimated completion	11 November 2021
Sites	1 location across United States

Drugs / interventions tested

Chewable plant sterol

Conditions studied

Hyperlipidemia — all drugs for Hyperlipidemia →

Sponsor

Piper Biosciences, Inc.

Who can join

18 and older, any sex, with Hyperlipidemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to measure the effectiveness of a twice daily plant sterol supplement, which is in a gummy format and packaged with health insights, in reducing LDL-C cholesterol in a real word setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hyperlipidemia

Currently open trials in the same condition.

NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
NCT07216482 — A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) · Phase 3 · recruiting
NCT06615609 — "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft · NA · recruiting
NCT07400549 — Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support T · NA · recruiting
NCT06603363 — Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04642742 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Piper Biosciences, Inc.
Last refreshed: 24 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04642742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing